Tokio Marine Asset Management Co. Ltd. Sells 2,483 Shares of UnitedHealth Group Inc. (UNH)
Tokio Marine Asset Management Co. Ltd. decreased its stake in UnitedHealth Group Inc. (NYSE:UNH) by 2.2% during the second quarter, Holdings Channel reports. The institutional investor owned 110,122 shares of the healthcare conglomerate’s stock after selling 2,483 shares during the period. UnitedHealth Group makes up about 1.6% of Tokio Marine Asset Management Co. Ltd.’s holdings, making the stock its 10th largest position. Tokio Marine Asset Management Co. Ltd.’s holdings in UnitedHealth Group were worth $15,549,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also bought and sold shares of the company. Tiemann Investment Advisors LLC raised its stake in shares of UnitedHealth Group by 5.0% in the first quarter. Tiemann Investment Advisors LLC now owns 5,265 shares of the healthcare conglomerate’s stock worth $679,000 after buying an additional 250 shares during the period. Virginia Retirement System purchased a new stake in shares of UnitedHealth Group during the first quarter worth approximately $42,348,000. Nisa Investment Advisors L.L.C. raised its stake in shares of UnitedHealth Group by 0.5% in the first quarter. Nisa Investment Advisors L.L.C. now owns 374,592 shares of the healthcare conglomerate’s stock worth $48,285,000 after buying an additional 1,800 shares during the period. Thomas White International Ltd. raised its stake in shares of UnitedHealth Group by 0.3% in the first quarter. Thomas White International Ltd. now owns 17,228 shares of the healthcare conglomerate’s stock worth $2,220,000 after buying an additional 50 shares during the period. Finally, Mn Services Vermogensbeheer B.V. purchased a new stake in shares of UnitedHealth Group during the first quarter worth approximately $2,702,000. Hedge funds and other institutional investors own 85.78% of the company’s stock.
Shares of UnitedHealth Group Inc. (NYSE:UNH) traded down 0.24% on Tuesday, hitting $138.16. The stock had a trading volume of 2,452,575 shares. UnitedHealth Group Inc. has a 1-year low of $107.51 and a 1-year high of $144.48. The company has a market capitalization of $131.58 billion, a PE ratio of 21.62 and a beta of 0.57. The firm has a 50-day moving average of $138.21 and a 200 day moving average of $136.26.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, July 19th. The healthcare conglomerate reported $1.96 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.89 by $0.07. UnitedHealth Group had a net margin of 3.51% and a return on equity of 19.08%. The company earned $46.50 billion during the quarter, compared to analyst estimates of $45.05 billion. On average, equities analysts anticipate that UnitedHealth Group Inc. will post $7.90 earnings per share for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 20th. Investors of record on Friday, September 9th were paid a $0.625 dividend. The ex-dividend date of this dividend was Tuesday, September 6th. This represents a $2.50 dividend on an annualized basis and a yield of 1.81%. UnitedHealth Group’s dividend payout ratio is 39.12%.
A number of analysts have recently commented on UNH shares. Mizuho boosted their price target on UnitedHealth Group from $156.00 to $160.00 and gave the company a “buy” rating in a report on Tuesday, July 19th. Credit Suisse Group AG reiterated a “buy” rating and set a $148.00 target price on shares of UnitedHealth Group in a report on Wednesday, June 29th. Leerink Swann reiterated a “buy” rating on shares of UnitedHealth Group in a report on Friday, June 10th. Citigroup Inc. upped their target price on UnitedHealth Group from $148.00 to $164.00 and gave the stock a “buy” rating in a report on Wednesday, July 20th. Finally, Argus upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $170.00 target price on the stock in a report on Friday, July 22nd. One equities research analyst has rated the stock with a hold rating, twenty-four have issued a buy rating and one has issued a strong buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus target price of $155.35.
In related news, Director Richard T. Burke sold 40,000 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, September 7th. The shares were sold at an average price of $135.31, for a total value of $5,412,400.00. Following the completion of the transaction, the director now directly owns 2,003,550 shares in the company, valued at approximately $271,100,350.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 1.65% of the stock is currently owned by corporate insiders.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc. (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.